AKAP9 Antibody

Product Specifications

NCBI Gene ID

10142

Swiss Prot

Q99996

Accession Number

NP_005742.4, NP_671714.1

Host

Goat

Reactivity

Human

Immunogen

The immunogen for this antibody is: C-SGSTTQFHAGMR

Clonality

Polyclonal

Conjugation

Unconjugated

Type

Primary Antibodies

Field of Research

Cancer

Purification

Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Concentration

500 ug/mL

Homology

Expected Species Reactivity based on sequence homology: Mouse

Buffer

Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. Aliquot and store at -20°C. Minimize freezing and thawing.

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Aliquot and store at -20˚ C. Minimize freezing and thawing.

Specificity

This antibody is expected to recognise isoforms 2 and 3 (NP_005742.4; NP_671714.1 respectively) . The isoforms Yotiao, AKAP350B and AKAP350C are not recognized.

Applications Notes

Peptide ELISA: Western Blot:Immunofluorescence:

Symbol

AKAP9

NCBI Official Name

A kinase (PRKA) anchor protein 9

NCBI Organism

Homo sapiens

Background Reference 01

Ciampi R, Knauf JA, Kerler R, Gandhi M, Zhu Z, Nikiforova MN, Rabes HM, Fagin JA, Nikiforov YE. Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. J Clin Invest. 2005 Jan;115 (1) :94-101.

Other Product Names

AKAP9, CG-NAP, PRKA9, YOTIAO, AKAP350, HYPERION, KIAA0803, A kinase (PRKA) anchor protein (yotiao) 9, AKAP120-like protein, kinase N-associated protein, A-kinase anchoring protein 450, A-kinase anchor protein, 350kDa, protein kinase A anchoring protein 9, centrosome- and golgi-localized protein, AKAP450, MU-RMS-40.16A, A-kinase anchor protein 9, AKAP9-BRAF fusion protein